CGEN Q4 2023 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$202M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$33M+346.1% YoY

Gross Profit

$31M94.0% margin

Operating Income

$18M53.7% margin

Net Income

$10M29.0% margin

EPS (Diluted)

$0.11

QoQ Revenue Growth

+Infinity%

Balance Sheet

Total Assets

$121M

Total Liabilities

$56M

Stockholders' Equity

$66M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$8M	+346.1%
Gross Profit	$31M	$7M	+382.1%
Operating Income	$18M	-$4M	+609.6%
Net Income	$10M	-$3M	+414.1%